Pay in 4 interest-free payments of $6.06 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
GLP-1 drugs (exenatide, liraglutide etc), as well as GIP/GLP-1 hybrid peptides (tirzepatide), are clinically approved for diabetes and/or obesity, with GLP-2 based drugs (teduglutide) approved for the treatment of short bowel syndrome
Gorilla Mode AR helps your body use fat for energy more effectively and makes better use of testosterone, which can make it easier to lean out or maintain a lean physique
While both are GLP-1 receptor agonists, tirzepatide additionally targets GIP receptors, presenting advantageous results in weight loss and metabolic improvements
Combined Use: Some protocols pair both peptides to maximize GH release
Lori Sussel, PhD
